[Federal Register Volume 76, Number 208 (Thursday, October 27, 2011)]
[Pages 66733-66734]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-27863]



National Institutes of Health

National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2) notice is hereby given of the following 
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c) (4) and 552b(c) (6), Title 5 
U.S.C., as amended. The purpose of this meeting is to evaluate requests 
for preclinical

[[Page 66734]]

development resources for potential new therapeutics for the treatment 
of cancer. The outcome of the evaluation will provide information to 
internal NCI committees that will decide whether NCI should support 
requests and make available contract resources for development of the 
potential therapeutic to improve the treatment of various forms of 
cancer. The research proposals and the discussions could disclose 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the proposed research projects, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, NCI Experimental Therapeutics Program (NExT).
    Date: December 7, 2011.
    Time: 8:30 a.m.-4:30 p.m.
    Agenda: To evaluate the NCI Experimental Therapeutics Program 
    Place: Marriott North Conference Center, 5701 Marinelli Road, 
Rockville, MD 20852.
    Contact Person: Dr. Barbara Mroczkowski, Executive Secretary, 
NCI Experimental Therapeutics Program, National Cancer Institute, 
NIH, 31 Center Drive, Room 3A44, Bethesda, MD 20817, (301) 496-4291, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: October 21, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-27863 Filed 10-26-11; 8:45 am]